LoadingWorld Markets / China STAR 50 /
Last close 253.00999451 on 2026-11-02
Founded: 2006
Founders: Zhu Yi
Sichuan Biokin develops oncology drugs, notably bispecific antibodies and antibody-drug conjugates, and licensed its bispecific ADC BL-B01D1 to Bristol Myers Squibb through its subsidiary SystImmune. It listed on the STAR Market in January 2023.
